Svetlana Bergelson

At Biogen, Svetlana is leading a team of scientists and analysts located in Cambridge, MA and RTP, NC. The group provides analytical support for Gene therapy and Protein modalities at all stages of development, from R-D transition through commercial. Main responsibilities include development, qualification, automation, implementation and transfer of analytical methods to support process development, product characterization, batch release and stability, as well as CMC program support.

Svetlana has over 20 years of experience in the biopharmaceutical industry. Prior to joining Biogen in 2005, she worked at two companies focused on anti-viral drug development. Her educational training includes M.Sc. in Biochemistry and Virology from Moscow State University (Russia), a PhD in Molecular Biology from Weizmann Institute of Science (Israel) and a post-doctoral fellowship at Whitehead Institute at MIT (USA).